This company has been marked as potentially delisted and may not be actively trading. Oaktree Acquisition (OAC) Competitors Add Compare Share Share Competitors Stock AnalysisCompetitorsTrendsBuy This Stock OAC vs. TDOC, AUNA, SBC, LFMD, TOI, AIRS, SHLT, CCM, HIMS, and NVSTShould you be buying Oaktree Acquisition stock or one of its competitors? The main competitors of Oaktree Acquisition include Teladoc Health (TDOC), Auna (AUNA), SBC Medical Group (SBC), LifeMD (LFMD), Oncology Institute (TOI), AirSculpt Technologies (AIRS), SHL Telemedicine (SHLT), Concord Medical Services (CCM), Hims & Hers Health (HIMS), and Envista (NVST). Oaktree Acquisition vs. Teladoc Health Auna SBC Medical Group LifeMD Oncology Institute AirSculpt Technologies SHL Telemedicine Concord Medical Services Hims & Hers Health Envista Oaktree Acquisition (NYSE:OAC) and Teladoc Health (NYSE:TDOC) are both small-cap medical companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, analyst recommendations, community ranking, institutional ownership, risk, earnings, media sentiment, dividends and valuation. Do institutionals and insiders believe in OAC or TDOC? 47.6% of Oaktree Acquisition shares are held by institutional investors. Comparatively, 76.8% of Teladoc Health shares are held by institutional investors. 0.6% of Teladoc Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term. Which has more volatility & risk, OAC or TDOC? Oaktree Acquisition has a beta of 0.17, meaning that its stock price is 83% less volatile than the S&P 500. Comparatively, Teladoc Health has a beta of 1.73, meaning that its stock price is 73% more volatile than the S&P 500. Which has stronger earnings & valuation, OAC or TDOC? Oaktree Acquisition has higher earnings, but lower revenue than Teladoc Health. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioOaktree AcquisitionN/AN/A$1.15MN/AN/ATeladoc Health$2.57B0.49-$220.37M-$5.88-1.22 Is OAC or TDOC more profitable? Oaktree Acquisition has a net margin of 0.00% compared to Teladoc Health's net margin of -37.91%. Oaktree Acquisition's return on equity of 0.00% beat Teladoc Health's return on equity.Company Net Margins Return on Equity Return on Assets Oaktree AcquisitionN/A N/A N/A Teladoc Health -37.91%-10.06%-4.86% Does the MarketBeat Community favor OAC or TDOC? Teladoc Health received 680 more outperform votes than Oaktree Acquisition when rated by MarketBeat users. However, 100.00% of users gave Oaktree Acquisition an outperform vote while only 62.78% of users gave Teladoc Health an outperform vote. CompanyUnderperformOutperformOaktree AcquisitionOutperform Votes3100.00% Underperform VotesNo VotesTeladoc HealthOutperform Votes68362.78% Underperform Votes40537.22% Does the media prefer OAC or TDOC? In the previous week, Teladoc Health had 10 more articles in the media than Oaktree Acquisition. MarketBeat recorded 10 mentions for Teladoc Health and 0 mentions for Oaktree Acquisition. Oaktree Acquisition's average media sentiment score of 0.00 beat Teladoc Health's score of -0.08 indicating that Oaktree Acquisition is being referred to more favorably in the media. Company Overall Sentiment Oaktree Acquisition Neutral Teladoc Health Neutral Do analysts rate OAC or TDOC? Teladoc Health has a consensus price target of $10.71, suggesting a potential upside of 48.93%. Given Teladoc Health's stronger consensus rating and higher probable upside, analysts clearly believe Teladoc Health is more favorable than Oaktree Acquisition.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Oaktree Acquisition 0 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 0.00Teladoc Health 0 Sell rating(s) 12 Hold rating(s) 7 Buy rating(s) 0 Strong Buy rating(s) 2.37 SummaryTeladoc Health beats Oaktree Acquisition on 9 of the 15 factors compared between the two stocks. Get Oaktree Acquisition News Delivered to You Automatically Sign up to receive the latest news and ratings for OAC and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NYSE and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart OAC vs. The Competition Export to ExcelMetricOaktree AcquisitionOffices & Clinics Of Medical Doctors IndustryMedical SectorNYSE ExchangeMarket Cap$706.63M$1.01B$5.46B$18.79BDividend YieldN/AN/A5.43%4.09%P/E RatioN/A16.4522.4332.61Price / SalesN/A1.10391.4228.44Price / Cash377.4536.0138.1817.53Price / Book140.459.246.684.45Net Income$1.15M-$52.07M$3.22B$1.02B Oaktree Acquisition Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)OACOaktree AcquisitionN/A$28.09-0.2%N/A+128.9%$706.63MN/A0.00N/AHigh Trading VolumeTDOCTeladoc Health3.4788 of 5 stars$6.78+4.1%$10.82+59.8%-44.7%$1.18B$2.57B-1.175,100Upcoming EarningsAnalyst ForecastAUNAAuna3.8976 of 5 stars$6.71+0.3%$13.05+94.5%-1.0%$496.34M$4.39B17.6614,958SBCSBC Medical GroupN/A$4.01-2.4%N/AN/A$415.48M$205.42M0.00N/ALFMDLifeMD2.6803 of 5 stars$5.51+2.1%$11.43+107.3%-49.0%$245.88M$212.45M-8.62230Short Interest ↓News CoveragePositive NewsTOIOncology Institute0.7309 of 5 stars$2.72+13.8%N/A+187.8%$207.64M$393.41M-3.52660Gap DownAIRSAirSculpt Technologies1.6068 of 5 stars$1.69-0.4%$3.75+121.4%-65.1%$98.41M$180.35M-12.00240Upcoming EarningsNews CoverageSHLTSHL TelemedicineN/A$2.05flatN/AN/A$33.61M$55.94M0.00583CCMConcord Medical Services0.6209 of 5 stars$4.36+2.2%N/A-10.9%$18.91M$471.70M0.00970Analyst ForecastShort Interest ↑News CoverageHIMSHims & Hers Health3.7802 of 5 stars$25.94+0.4%$38.25+47.5%+124.8%$5.75B$1.48B58.81650Analyst ForecastInsider TradeGap DownNVSTEnvista4.5223 of 5 stars$14.91+0.3%$19.96+33.9%-21.7%$2.57B$2.51B-2.3012,700Upcoming EarningsNews Coverage Related Companies and Tools Related Companies Teladoc Health Competitors Auna Competitors SBC Medical Group Competitors LifeMD Competitors Oncology Institute Competitors AirSculpt Technologies Competitors SHL Telemedicine Competitors Concord Medical Services Competitors Hims & Hers Health Competitors Envista Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NYSE:OAC) was last updated on 4/27/2025 by MarketBeat.com Staff From Our PartnersElon Set to Shock the World by May 1st ?Tech legend Jeff Brown recently traveled to the industrial zone of South Memphis to investigate what he believ...Brownstone Research | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredGet Your Bank Account “Fed Invasion” Ready with THESE 4 Simple StepsStarting as soon as a few months from now, the United States government will make a sweeping change to bank ac...Weiss Ratings | SponsoredGold Hits New Highs as Global Markets SpiralWhen Trump took office in 2017, gold was just $1,100 an ounce. By the time he left, it had soared to $1,839. ...Premier Gold Co | Sponsored"I'm risking my reputation on this"I've discovered something so significant about the 2025 crypto market that I had to put everything else aside ...Crypto 101 Media | SponsoredURGENT: This Altcoin Opportunity Won’t Wait – Act NowMy friends Joel and Adam have a simple motto: "For us, it's always a bull market." That’s because their 92%...Crypto Swap Profits | SponsoredTrump’s tariffs just split the AI market in twoTrump’s tariff just split the AI market – among others – in two. One group of AI companies—the ones relying...Traders Agency | SponsoredAltucher: Turn $900 into $108,000 in just 12 months?We are entering the final Trump Bump of our lives. But the biggest returns will not be in the stock market.Paradigm Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Oaktree Acquisition Corp. Please log in to your account or sign up in order to add this asset to your watchlist. Share Oaktree Acquisition With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.